US biopharma firm Zentalis raises $20m Series A funding for new JV

US biopharma firm Zentalis raises $20m Series A funding for new JV

Laboratory equipment. Photo: Pixabay

21 May, 2020

Tybourne Capital Management Zentalis Pharmaceuticals

Printed by Unregistered user on Thu, 18 Dec 2025 19:44:28 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

Temasek leads $65m Series D round in US-based SQZ Biotechnologies

Chinese biopharma Mabwell raises $278m in Series A round led by Shiyu Capital

Read more from Greater China

China’s Momenta partners Grab for autonomous driving in SE Asia

Climate Tech & ESG

China solar industry’s losses narrow in Q3 as Beijing reins in overcapacity